Average Co-Inventor Count = 2.30
ph-index = 20
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. E.i. Dupont De Nemours and Company (24 from 16,338 patents)
2. The United States of America, as Represented by the Secretary, Department of Health and Human Services (20 from 3,540 patents)
3. Other (1 from 832,917 patents)
4. Mars, Incorporated (1 from 1,198 patents)
5. Immunocore Limited (1 from 45 patents)
46 patents:
1. 12441778 - T cell receptors recognizing HLA-A1-restricted MAGE-A3
2. 11879017 - Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
3. 11306131 - T cell receptors recognizing HLA-A1- or HLA-CW7-restricted mage
4. 11124580 - Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
5. 10864252 - Anti-SSX-2 T cell receptors and related materials and methods of use
6. 10570214 - Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
7. 10407485 - Murine anti-NY-ESO-1 T cell receptors
8. 10143724 - Anti-SSX-2 T cell receptors and related materials and methods of use
9. 10087230 - Murine anti-NY-ESO-1 T cell receptors
10. 9688739 - T cell receptors and related materials and methods of use
11. 9624306 - Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
12. 9487573 - Murine anti-NY-ESO-1 T cell receptors
13. 9345748 - Anti-SSX-2 T cell receptors and related materials and methods of use
14. 9266960 - Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
15. 9128080 - Modified T cell receptors and related materials and methods